share_log
Breakings ·  Nov 28 05:45
Applied Therapeutics Shares Down 82.73% at $1.48 in Extended Trade After US FDA Declines to Approve Genetic Disease Drug
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment